Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia

  • 1203-P: Cause of Hospitalizations in Patients with Type 2 Diabetes Mellitus (T2DM) in the CANVAS Program

    Diabetes Date published:

  • 1216-P: The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program

    Diabetes Date published:

  • 1206-P: Effects of Canagliflozin (CANA) on Initiation of Insulin in CANVAS Program

    Diabetes Date published:

  • FP484DIFFERENT eGFR THRESHOLDS AND THE RENAL EFFECTS OF CANAGLIFLOZIN: DATA FROM THE CANVAS PROGRAM

    Nephrology Dialysis Transplantation Date published:

  • Department of Error

    The Lancet Date published:

  • The performance and potential of the Australasian Health Star Rating system: a four-year review using the RE-AIM framework

    Australian and New Zealand Journal of Public Health Date published:

  • Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus

    Circulation Date published:

  • The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24-hour, spot, and short duration (<24 hours) timed urine collections to assess dietary sodium intake

    The Journal of Clinical Hypertension Date published:

  • Can front-of-pack nutrition labels overcome any biasing effects of nutrient and health claims?

    Obesity Research & Clinical Practice Date published:

  • Abstract #259 Cardiovascular and Renal Outcomes with Canagliflozin in People with Type 2 Diabetes According to Baseline use of Metformin

    Endocrine Practice Date published:

  • Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

    Diabetologia Date published:

  • Abstract P294: Estimated Benefits and Risks of Lowering Sodium Intake With Potassium-based Salt Substitutes in China: a Modelling Study

    Circulation Date published:

  • Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis

    Diabetes, Obesity and Metabolism Date published:

  • Estimating the health benefits and cost-savings of a cap on the size of single serve sugar-sweetened beverages

    Preventive Medicine Date published:

  • EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE OUTCOMES WITH AND WITHOUT PRESERVED EJECTION FRACTION IN TYPE 2 DIABETES: RESULTS FROM THE CANVAS PROGRAM

    Journal of the American College of Cardiology Date published:

  • Sources of Dietary Salt in North and South India Estimated from 24 Hour Dietary Recall

    Nutrients Date published: